Jin Jin

Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial

Kelong Han, Jin Jin, Mauricio Maia et al. · The AAPS Journal · 2014 · 48 citations · Full text

Altered Pharmacokinetics, Cancer Management, Gastroenterology +16

Cancer‐associated fibroblast migration in non‐small cell lung cancers is modulated by increased integrin α11 expression

Moe Iwai, Miniwan Tulafu, Shinsaku Togo et al. · Molecular Oncology · 2021 · 48 citations · Full text

Integrin α11, Pathology, Cancer Biology +19

Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis

Yi He, Ruijie Liu, Mei Yang et al. · Frontiers in Oncology · 2021 · 22 citations · Full text

Exposure–Response and Tumor Growth Inhibition Analyses of the Monovalent Anti-c-MET Antibody Onartuzumab (MetMAb) in the Second- and Third-Line Non-Small Cell Lung Cancer

Kelong Han, Pascal Chanu, Fredrik Jönsson et al. · The AAPS Journal · 2016 · 14 citations · Full text

Phase Ii, Medicine, Pharmacology +15

Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β–ERK5 Interaction

Kotaro Kadoya, Shinsaku Togo, Miniwan Tulafu et al. · Cellular Physiology and Biochemistry · 2019 · 14 citations · Full text